GlassScriptPhysician profile
Evan William Conrad
NPI 1013547736
$5,072.86
in general payments reported to CMS, 2019-2025
37 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,055 · 2022: $1,626 · 2023: $841 · 2024: $504 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $577.40 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $525.47 | 2021-2025 | Erleada |
| Endo Pharmaceuticals INC. | $452.31 | 2021-2023 | Xiaflex, Aveed, Edex |
| Dendreon Pharmaceuticals LLC | $390.51 | 2021-2025 | Provenge |
| Astellas Pharma US INC | $358.06 | 2021-2025 | Xtandi, Veozah |
| Abbvie INC. | $263.50 | 2021-2023 | |
| Urogen Pharma, INC. | $261.20 | 2022-2025 | Jelmyto |
| Antares Pharma, INC. | $223.84 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| Pfizer INC. | $205.73 | 2021-2025 | |
| Amgen INC. | $162.36 | 2021-2022 | |
| Rochester Medical Corporation | $159.58 | 2021-2022 | |
| Procept Biorobotics Corporation | $148.23 | 2022-2024 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $138.44 | 2022-2025 | |
| Integra Lifesciences Corporation | $133.07 | 2021-2024 | Medihoney, Biofix, Biodrestore |
| Olympus America INC. | $119.27 | 2022-2024 | Itind System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $113.01 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $103.16 | 2021-2024 | Axonics |
| Merck Sharp & Dohme LLC | $94.09 | 2021-2023 | Lynparza, Keytruda |
| Teleflex LLC | $82.27 | 2022-2025 | Urolift, Barrigel |
| Urovant Sciences INC | $65.86 | 2021-2022 | |
| Tolmar, INC. | $52.71 | 2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $51.34 | 2025 | Adstiladrin |
| Convatec INC. | $45.57 | 2023 | |
| Azurity Pharmaceuticals, INC. | $42.57 | 2025 | Azmiro |
| Boston Scientific Corporation | $42.18 | 2024-2025 | Moses 550 Dfl, General - Female Sui |
| Medtronic, INC. | $37.26 | 2025 | V-Loc 180 |
| Progenics Pharmaceuticals, INC. | $34.43 | 2022-2024 | |
| Myovant Sciences INC. | $29.68 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $28.24 | 2021 | |
| Blue Earth Diagnostics | $23.74 | 2022 | |
| Ethicon US, LLC | $22.26 | 2025 | Echelon; Endopath |
| Immunitybio, INC. | $20.96 | 2025 | |
| Calyxo, INC. | $15.59 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $14.30 | 2023 | Prolaris |
| Verity Pharmaceuticals INC. | $14.21 | 2023 | Trelstar |
| Travere Therapeutics, INC. | $11.28 | 2021 | |
| Mission Pharmacal Company | $9.18 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.